English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/62551
Share/Impact:
Statistics
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:
Title

Peripheral blood dendritic cell subsets from patients with monoclonal gammopathies show an abnormal distribution and are functionally impaired

AuthorsMartín-Ayuso, Marta; Almeida, Julia ; Pérez-Andrés, Martin; San Miguel, Jesús F. ; Orfao, Alberto
Issue Date2008
PublisherAlphaMed Press
CitationOncologist 13(1): 82-92 (2008)
Abstract[Objectives]: The information currently available about dendritic cells (DCs) in patients with different types of monoclonal gammopathy (MG) is limited and frequently controversial. In the present study, we analyzed the ex vivo distribution as well as the phenotypic and functional characteristics of peripheral blood (PB) DCs from different types of MG. [Methods]: For this purpose, 61 untreated patients in total with MG were analyzed - MG of undetermined significance (MGUS), 29 cases; multiple myeloma (MM), 28 cases; and plasma cell leukemia (PCL), 4 cases - in comparison with a group of 10 healthy controls. [Results]: Our results show an absolute overall higher number of all subsets of PB DCs in PCL, together with lower numbers of myeloid DCs in MM patients. From a phenotypic point of view, PB DC subsets from all types of MG expressed significantly higher levels of HLA molecules and altered patterns of expression of the CD2, CD11c, CD16, CD22, CD62L, and CD86 molecules, in association with altered patterns of secretion of inflammatory cytokines. [Conclusion]: In summary, we show the existence of significant abnormalities in the distribution, phenotype, and pattern of secretion of inflammatory cytokines by different subsets of PB DCs from patients with MGs, which could reflect a potentially altered homing of DCs, together with a greater in vivo activation and lower responsiveness of PB DCs, which are already detectable in MGUS patients. ©AlphaMed Press.
URIhttp://hdl.handle.net/10261/62551
DOI10.1634/theoncologist.2007-0127
Identifiersdoi: 10.1634/theoncologist.2007-0127
issn: 1083-7159
e-issn: 1549-490X
Appears in Collections:(IBMCC) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
View/Open
Show full item record
 

Related articles:


WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.